FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

User Fee Bill Aims to Correct Court Decisions

A House Energy and Commerce Committee legislative package to reauthorize FDA user fee agreements aims to address agency predicaments caused by recent ...

Federal Register

Guide on Radiolabeled Mass Balance Studies

Federal Register notice: FDA makes available a draft guidance entitled Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studie...

Medical Devices

FDA Clears Dental Caries AI Detector

FDA clears a VideaHealth 510(k) for its Videa Caries Assist, an artificial intelligence-powered dental caries (cavity) detection algorithm.

Biologics

FDA Limits Use of Janssen Vaccine Due to Clot Risk

FDA limits the emergency use authorization of Janssens Covid-19 vaccine to certain individuals 18 years of age and older due to the risk of thrombosis...

Medical Devices

Correlating Device Inspections with Warning Letters

Attorney Bradley Thompson uses data analysis to determine medical device inspection observations that more frequently are associated with Warning Lett...

Federal Register

Anesthetic/Analgesic Drugs Panel Renewal

Federal Register notice: FDA announces its renewal of the Anesthetic and Analgesic Drug Products Advisory Committee for an additional two years beyond...

Federal Register

Guide on Circulating Tumor DNA Drug Development

Federal Register notice: FDA makes available a draft guidance entitled Use of Circulating Tumor DNA for Early-Stage Solid Tumor Drug Development.

Human Drugs

More Transparency in Advisory Committee Use Needed: Researchers

Harvard University researchers who looked at FDAs use of advisory committees for new drugs say reforms in the process would improve transparency and a...

Human Drugs

Paxlovid Widely Available in Pharmacies: Farley

CDER Office of Infectious Diseases director John Farley answers healthcare provider questions about using Pfizers Paxlovid on authorized Covid-19 pati...

Medical Devices

FDA OKs Marketing of New Alzheimers Diagnostic

FDA permits marketing of a Fujirebio in vitro diagnostic test for Alzheimers disease.